Beware injections of investor enthusiasm https://t.co/OTFxCmwksT via @FT
— The Propell Group (@ThePropellGroup) October 8, 2016
#healthtech
Beware injections of investor enthusiasm https://t.co/OTFxCmwksT via @FT
— The Propell Group (@ThePropellGroup) October 8, 2016
#healthtech